{"id":298949,"date":"2020-08-06T22:18:25","date_gmt":"2020-08-06T20:18:25","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=298949"},"modified":"2020-08-06T22:18:25","modified_gmt":"2020-08-06T20:18:25","slug":"u-rusiji-patentiran-lijek-koji-pomaze-protiv-virusa-korona","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2020\/08\/06\/u-rusiji-patentiran-lijek-koji-pomaze-protiv-virusa-korona\/","title":{"rendered":"U Rusiji patentiran lijek koji poma\u017ee protiv virusa korona"},"content":{"rendered":"<p>&#8220;Nakon zavr\u0161etka klini\u010dkih ispitivanja i registracije lijeka u Ministarstvu zdravlja, Nau\u010dni centar za biomedicinske tehnologije FMBA Rusije \u0107e moc\u0301i da pokrene masovnu proizvodnju lijeka, kako bi ljekari uz njegovu pomoc\u0301 mogli da se izbore sa komplikacijama koje se razvijaju kod pacijenata sa virusom korona koje dovode do smrtnog ishoda\u201c, navodi se u saop\u0161tenju FMBA.<\/p>\n<p>Kako je obja\u0161njeno, uobi\u010dajeni naziv originalnog lijeka je &#8216;Dalargin&#8217; i on je kori\u0161\u0107en za lije\u010denje \u010dira na \u017eelucu, akutnog pankreatitisa i nekroze pankreasa. Istra\u017eiva\u010di su ga koristili za stvaranje novog lijeka protiv virusa korona. Svoj razvoj nazvali su &#8216;Lejtragin&#8217;. Istra\u017eivanja su pokazala da je najefikasniji na\u010din upotrebe inhalacija.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Federalna biomedicinska agencija (FMBA) Rusije je patentirala domac\u0301i lijek koji mo\u017ee da sprije\u010di ili ubla\u017ei citokinemi\u010dku eksploziju (hipercitokinemiju) koju izaziva virus korona, prenosi Sputnjik.<\/p>\n","protected":false},"author":1,"featured_media":282975,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-298949","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/298949","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=298949"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/298949\/revisions"}],"predecessor-version":[{"id":298950,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/298949\/revisions\/298950"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/282975"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=298949"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=298949"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=298949"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}